We also showed the activation of p53 by the p53-MDM2 inhibitor nutlin3a in mesothelioma cell lines, thus confirming the presence of a p53 wild type in this tumor type and the p53 reactivating properties of a MDM2-p53 inhibitor. The gene discussed is MDM2; the disease is neoplasm.